A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/11/2011	US8034829 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
10/11/2011	US8034828 Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis
10/11/2011	US8034827 Phenanthridine derivatives as bradykinin antagonists
10/11/2011	US8034826 Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors
10/11/2011	US8034825 Chemically modified small molecules
10/11/2011	US8034824 Iontophoretic preparation for treatment of breast cancer and/or mastitis
10/11/2011	US8034823 Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
10/11/2011	US8034822 Glucokinase activators
10/11/2011	US8034821 Selective serine/threonine kinase inhibitors
10/11/2011	US8034820 Pharmaceutical composition
10/11/2011	US8034819 Glucokinase activator
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034817 Inhalation of quinolinonecarboxylic acid compound
10/11/2011	US8034816 Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
10/11/2011	US8034815 Imidazol-1-yl-(4-pyridin-2-yl-piperazin-1-yl)-methanethione; Critical Outcome Technologies' Iead compound (COTI); kinase inhibitor; anticarcinogenic agent; especially small cell lung cancer; cervical, ovarian, skin, prostate, breast, colorectal, head, neck, or kidney cancer, sarcoma, leukemia
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034813 Polymorphs of brimonidine pamoate
10/11/2011	US8034812 Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034809 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
10/11/2011	US8034808 Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
10/11/2011	US8034807 Salts of bazedoxifene
10/11/2011	US8034806 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
10/11/2011	US8034805 Methods for the preparation of salts of 2-[2-(4-dibenzo[B,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxyl]ethanol (quetiapine) and for the purification thereof
10/11/2011	US8034804 (Pyrido/thieno)-[f]-oxazepine-5-one derivatives
10/11/2011	US8034803 Photodynamic therapy of occult age-related macular degeneration
10/11/2011	US8034802 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
10/11/2011	US8034800 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/11/2011	US8034799 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/11/2011	US8034798 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases
10/11/2011	US8034797 Triazene compounds for the treatment of cancer
10/11/2011	US8034796 Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
10/11/2011	US8034795 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
10/11/2011	US8034793 RNAi modulation of MLL-AF4 and uses thereof
10/11/2011	US8034789 Antisense compounds targeted to connexins and methods of use thereof
10/11/2011	US8034788 Composition and methods for skin care
10/11/2011	US8034776 Orallyl administering a zonulin antagonist comprising an octapeptide; monitoring; administering a gluten challenge; diagnosis of celiac disease by determining amount of interferons, interleukins, or nitrates in a sample and evaluating
10/11/2011	US8034765 Compositions and methods for preparation of poorly water soluble drugs with increased stability
10/11/2011	US8034740 Adsorptivity imparting agent containing porous silica
10/11/2011	US8034619 Polyamides for nucleic acid delivery
10/11/2011	US8034604 High viscosity xanthan polymer preparations
10/11/2011	US8034582 Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms
10/11/2011	US8034548 Methods and materials for assessing prostate cancer therapies
10/11/2011	US8034389 Cranberry seed oil extract and compositions containing components thereof
10/11/2011	US8034388 Plant extract as anticancer agents
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034377 DHA esters and use thereof in treatment and prevention of cardiovascular disease
10/11/2011	US8034374 Patch containing nonsteroidal anti-inflammatory and analgesic agent
10/11/2011	US8034373 Methods and compositions for reducing oxidative stress in an animal
10/11/2011	US8034371 Intranasal compositions
10/11/2011	US8034370 Active agent dispersed within a biodegradable polymer matrix; bioerodible
10/11/2011	US8034369 Controlled release bioactive agent delivery device
10/11/2011	US8034366 Poly lactic co-glycolic acid copolymer biodegradable polymer matrix; eye implant infused with ace-inhibitors, endogenous cytokines, agents that influence basement membrane, agents that influence the growth of endothelial cells, adrenergic agonists or blockers; uveitis, macular edema, macular degeneration
10/11/2011	US8034364 Implantable medical device comprising a pro-healing(ester-amide)
10/11/2011	US8034346 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	US8034334 Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
10/11/2011	US8034322 Polyurethane dispersions based on polycarbonate polyols and suitable for use in personal care products
10/11/2011	US8033981 Radioactive member and method of making
10/11/2011	DE202008018063U1 Pharmazeutischer Hilfsstoffkomplex Pharmaceutical excipient complex
10/11/2011	CA2727735C Disinfectant and/or bactericidal aqueous compositions
10/11/2011	CA2682494C Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
10/11/2011	CA2670482C Motilide polymorphs
10/11/2011	CA2655395C Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
10/11/2011	CA2602855C Cholesterol as an antibiotic for streptococcus pneumoniae
10/11/2011	CA2587328C New derivatives of porphyrin including chlorine and/or bacteriochlorins and their applications in photodynamic therapy
10/11/2011	CA2564372C Hiv integrase inhibitors
10/11/2011	CA2560781C Synthetic membrane anchors
10/11/2011	CA2555216C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
10/11/2011	CA2554070C Macrolides with antiinflammatory activity
10/11/2011	CA2553413C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2536977C Non-polar photosensitizer formulations for photodynamic therapy
10/11/2011	CA2529491C Hot liquid fiber product
10/11/2011	CA2524640C 2, 3, 4, 5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
10/11/2011	CA2520852C 7-([1,4]dioxan-2-yl)-benzothiazole derivative as adenosine receptor ligands
10/11/2011	CA2520523C Oral formulations of cladribine
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2513269C Repellent
10/11/2011	CA2508478C Withania somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof
10/11/2011	CA2506930C Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/11/2011	CA2494235C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2471436C Non-sedating barbituric acid derivatives
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2464578C Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
10/11/2011	CA2464322C Methods of treatment using a gastric retained gabapentin dosage
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/11/2011	CA2457027C Chitin microparticles and their medical uses
10/11/2011	CA2455768C Antitumoral analogs of et-736
10/11/2011	CA2454665C Modifying the fatty acid composition of cell membranes of organs and tissues
10/11/2011	CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011	CA2447663C Composition and use of substances for the stabilization of sulphur-containing amino acids
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2442151C Stable solution of reduced coenzyme q

1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 7860